Flexible partnerships.
Working to improve healthcare

 

Building partnerships is key to expand our portfolio to achieve sustainable double digit growth and ultimately achieve our Vision 2020 to be the ‘go to’ European specialist pharma partner of choice.

We want to win late stage partnering opportunities that will exploit our strengths and infrastructure in Europe, Australia and New Zealand.

We are committed to acquire specialised innovative products from companies in Europe, the US and elsewhere who have a complementary vision to improve patients’ lives. Through our agile and flexible organisation we have the ability to deploy a single opportunity across our entire network of affiliates or maximise opportunities locally.

We are focusing on specialist products which are:

  • Phase III ready
  • Going under registration
  • Already registered in the EU, Australia and New Zealand but not launched. 

 

 

 

Strong partnering track record

Many ways to partner: licensing, acquisition, joint venture, flexible deal structure

One Norgine:
a single integrated European model, 14 sites, over 1,000 people

Specialist therapy areas: gastroenterology, hepatology, cancer and supportive care

2016:
total revenue and income €368M

One Norgine.
A single integrated European model

 

One Norgine approach – we think globally but act locally.

 

We continue to deliver a strong performance

 

Despite the continuing difficulties in the European pharmaceutical market, we have grown our business at a faster rate than market growth.

 

Total revenue and income*

*total revenue and income consist of product sales, partnering milestones and other income

 

 

We partner in many different ways

icons

In-licensing and acquisition

We license in or acquire products in late stage development or already approved such that either -

we own the asset outright and control all future development
or
we share responsibility for future development in collaboration with the licensor

icons

Out-licensing

We make our products such as MOVICOL®, MOVIPREP® and PLENVU®, available to patients in territories where we do not have our own sales force by finding suitable partners and utilising their local knowledge and expertise

icons

Flexible deal structure

As a private company we are able to be creative and flexible in the structure of deals

Our specialist therapy areas

icons

Gastroenterology

icons

Hepatology

icons

Cancer and supportive care

Our partners